FdaApplication
NDA 205625
Identifiers
- fda_app_no: NDA205625
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND |
| application_type | NDA |
| approval_date | 2014-08-20 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ARNUITY ELLIPTA | FLUTICASONE FUROATE | 0.1MG/INH | POWDER;INHALATION |
| ARNUITY ELLIPTA | FLUTICASONE FUROATE | 0.05MG/INH | POWDER;INHALATION |
| ARNUITY ELLIPTA | FLUTICASONE FUROATE | 0.2MG/INH | POWDER;INHALATION |
3 products